Added to YB: 2023-07-18
Pitch date: 2023-07-18
MEIP [bullish]
Lite Strategy, Inc.
-70.84%
current return
Author Info
Clark Street Value is a special sits/event-driven investor. Sign up for the newsletter.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer.
Market Cap
$71.7M
Pitch Price
$5.86
Price Target
N/A
Dividend
N/A
EV/EBITDA
-3.14
P/E
-0.84
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
MEI Pharma: Flawed Deal w/ INFI, Activist Target
A summary for this pitch has not been created yet.
Read full article (1 min)